Literature DB >> 14037852

Sources of error in the biochemical diagnosis of muscular dystrophy.

W A THOMSON.   

Abstract

Entities:  

Keywords:  ENZYMES/blood; MUSCULAR DYSTROPHY/diagnosis

Mesh：

Substances：

Year:  1962        PMID： 14037852      PMCID： PMC495443          DOI： 10.1136/jnnp.25.3.191

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  53 in total

1.  [Study of arteriovenous differences during muscle diseases. 1. Oxygen, glucose & lactic acid. 2. Blood aldolase].

Authors:  J C DREYFUS; G SCHAPIRA; J DEMOS
Journal:  Clin Chim Acta       Date:  1958-11       Impact factor: 3.786

2.  An investigation of the carrier state in the Duchenne type muscular dystrophy.

Authors:  P LEYBURN; W H THOMSON; J N WALTON
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

3.  Dermatomyositis; a discussion of the recent literature and report of two cases.

Authors:  J BRUMLIK; H WACHS; W HUMMEL; B BOSHES
Journal:  Q Bull Northwest Univ Med Sch       Date:  1959

4.  The molecular turnover of muscle aldolase.

Authors:  G SCHAPIRA; J KRUH; J C DREYFUS; F SCHAPIRA
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

5.  Multiple serial enzyme studies in acute myocardial infarction.

Authors:  N R ROWELL; A J SMITH
Journal:  Br Med J       Date:  1959-09-19

6.  [Not Available].

Authors:  J C DREYFUS; G SCHAPIRA
Journal:  C R Seances Soc Biol Fil       Date:  1955-11

7.  Some alterations in serum enzymes in progressive muscular dystrophy.

Authors:  A A WHITE; W C HESS
Journal:  Proc Soc Exp Biol Med       Date:  1957-03

8.  [Aldolase excess in blood in myopathic mice].

Authors:  F SCHAPIRA; G SCHAPIRA; J C DREYFUS
Journal:  C R Hebd Seances Acad Sci       Date:  1957-08-05

9.  [Changes of serum aldolase activity in the neonatal period in physiological, para-physiological and pathological conditions].

Authors:  L MARTONI; S MUSIANI
Journal:  Clin Pediatr (Bologna)       Date:  1958-05

10.  [Transaminase determinations in obstetrics].

Authors:  U C DUBACH; H O STAMM
Journal:  Arch Gynakol       Date:  1958
View more
  10 in total

1.  LAEVADOSIN FOR MUSCULAR DYSTROPHY.

Authors:  W H THOMSON
Journal:  Br Med J       Date:  1964-10-31

2.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

3.  UNDESCENDED TESTES.

Authors:  R K CHANDRA
Journal:  Indian J Pediatr       Date:  1964-05       Impact factor: 1.967

4.  [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)].

Authors:  H W ROTTHAUWE; S KOWALEWSKI
Journal:  Klin Wochenschr       Date:  1965-02-01

5.  SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY.

Authors:  J STEPHENS; E LEWIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-04       Impact factor: 10.154

6.  Serum enzyme changes in muscle disease and their relation to tissue change.

Authors:  B P HUGHES
Journal:  Proc R Soc Med       Date:  1963-03

7.  Skeletal muscle glycogenosis: an investigation of two dissimilar cases.

Authors:  W H THOMSON; J C MACLAURIN; J W PRINEAS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-02       Impact factor: 10.154

8.  A trial of therapy by nucleosides and nucleotides in muscular dystrophy.

Authors:  W H THOMSON; K E GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

9.  Some Biochemical Aspects of the Myopathies.

Authors:  B P Hughes
Journal:  Postgrad Med J       Date:  1965-06       Impact factor: 2.401

10.  Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders.

Authors:  S Di Mauro; C Angelini; C Catani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-10       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.